Symptomatic intracranial atherosclerotic disease: What is the best treatment option?

Stroke

Volumn 39, Issue 6, 2008, Pages 1661-1662

  Gupta, Rishi ^a,b  

^a East Lansing   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Intracranial Stenosis; Stenting

Indexed keywords

ACETYLSALICYLIC ACID; WARFARIN;

ANGIOPLASTY; BRAIN ATHEROSCLEROSIS; BRAIN ISCHEMIA; EDITORIAL; HIGH RISK POPULATION; HUMAN; PRIORITY JOURNAL; RESTENOSIS; RISK ASSESSMENT; RISK FACTOR; STENT; SYMPTOM; TREATMENT OUTCOME; GRAFT OCCLUSION; INSTRUMENTATION; NOTE; PATHOPHYSIOLOGY; PATIENT SELECTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POSTOPERATIVE COMPLICATION; STANDARD; STATISTICS; STROKE;

ANGIOPLASTY, BALLOON; GRAFT OCCLUSION, VASCULAR; HUMANS; HYPOXIA-ISCHEMIA, BRAIN; INTRACRANIAL ARTERIOSCLEROSIS; PATIENT SELECTION; POSTOPERATIVE COMPLICATIONS; RISK ASSESSMENT; RISK FACTORS; STENTS; STROKE; TREATMENT OUTCOME;

EID: 46249087928     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.107.508507     Document Type: Editorial

References (16)

1. Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, Levine SR, Chaturvedi S, Kasner SE, Benesch CG, Sila CA, Jovin TG, Romano JG; Warfarin-Aspirin Symptomatic Intracranial Disease Trial Investigators. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med. 2005;31:1305-1316.
2. Kasner SE, Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, Levine SR, Chaturvedi S, Benesch CG, Sila CA, Jovin TG, Romano JG, Cloft HJ; Warfarin Aspirin Symptomatic Intracranial Disease Trial Investigators. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation. 2006;113:555-563.
3. Chaturvedi S, Turan TN, Lynn MJ, Kasner SE, Romano J, Cotsonis G, Frankel M, Chimowitz MI; for the WASID Study Group. Risk factor status and vascular events in patients with symptomatic intracranial stenosis. Neurology. 2007;69:2063-2068.
4. Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hun-ninghake DB, Pasternak RC, Smith SC Jr, Stone NJ; National Heart, Lung, and Blood Institute: American College of Cardiology Foundation: American Heart Association. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation. 2004;110:227-239.
5. Elkind MSV, Curtis B. Lowering cholesterol in patients with stroke: raising the standard. Neurology. 2006;66:1140-1141.
6. Sundt TM Jr, Smith HC, Campbell JK, Vliestra RE, Cucchiara RF, Stanson AW. Transluminal angioplasty for basilar artery stenosis. Mayo Clin Proc. 1980;55:673-680.
7. Freitas JMM, Zenteno M, Aburto-Murrieta Y, Koppe G, Abath C, Nunes JA, Raupp E, Hidalgo R, Pieruccetti MA, Lee A. Intracranial arterial stenting for symptomatic stenoses: a Latin American experience. Surg Neurol. 2007;68:378-386.
8. Jiang WJ, Xu XT, Du B, Dong KH, Jin M, Wang QH, Ma N. Comparison of elective stenting of severe vs moderate intracranial atherosclerotic stenosis. Neurology. 2007;68:420-426.
9. Fiorella D, Levy EI, Turk AS, Albuquerque FC, Niemann DB, Aagaard-Kienitz B, Hanel RA, Woo H, Rasmussen PA, Hopkins LN, Masaryk TJ, McDougall CG. US multicenter experience with the wingspan stent system for the treatment of intracranial atheromatous disease: peripro-cedural results. Stroke. 2007;38:881- 887.
10. Bose A, Hartmann M, Henkes H, Liu HM, Teng MM, Szikora I, Berlis A, Reul J, Yu SC, Forsting M, Lui M, Lim W, Sit SP. A novel, self-expanding, nitinol stent in medically refractory intracranial atherosclerotic stenoses: the Wingspan study. Stroke. 2007;38:1531-1537.
11. Levy EI, Turk AS, Albuquerque FC, Niemann DB, Aagaard-Kienitz B, Pride L, Purdy P, Welch B, Woo H, Rasmussen PA, Hopkins LN, Masaryk TJ, McDougall CG, Fiorella DJ. Wingspan in-stent restenosis and thrombosis: incidence, clinical presentation and management. Neurosurgery. 2007;61:644-650.
12. Kallmes DF, Do HM. Wherefore Wingspan? AJNR Am J Neuroradiol. 2007;28:997-998.
13. Mazighi M, Yadav J, Abou-Chebl A. Durability of endovascular therapy for symptomatic intracranial atherosclerosis. Stroke. 2008;39:1766 -1769.
14. SSYLVIA Study Investigators. Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA): study results. Stroke. 2004;35:1388-1392.
15. Mercado N, Boersma E, Wijns W, Gersh BJ, Morillo CA, de Valk V, van Es GA, Grobbeee DE, Serruys PW. Clinical and quantitative coronary angiographic predictors of coronary restenosis: a comparative analysis from the balloon-to-stent era. J Am Coll Cardiol. 2001;38:645-652.
16. Derdeyn CP, Chimowitz MI. Angioplasty and stenting for atherosclerotic intracranial stenosis: rationale for a randomized clinical trial. Neuroimaging Clin N AM. 2007;17:355-333.